JP Morgan Reinstates Overweight on PACS Group, Announces $44 Price Target
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.